Scott Samuels

Secretary, General Counsel & Senior Vice President at BeiGene Ltd.

Scott Samuels

Scott Samuels

Secretary, General Counsel & Senior Vice President at BeiGene Ltd.

Overview
Career Highlights

ARIAD Pharmaceuticals, Inc.
BeiGene Ltd.

RelSci Relationships

1554

Number of Awards

2

Contact Data
Trying to get in touch with Scott Samuels? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Scott Samuels likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chair of the Securities Practice Group at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Member (Attorney) at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Relationship likelihood: Strong

Executive Vice President, General Counsel & Secretary at Intra-Cellular Therapies, Inc.

Relationship likelihood: Strong

Chair, Life Sciences Practice at Goodwin Procter LLP

Relationship likelihood: Strong

Partner at Goodwin Procter LLP

Relationship likelihood: Strong

Professional at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Relationship likelihood: Strong

President & Director at ARIAD Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Scott Samuels
Potential Connections via
Relationship Science
You
Scott Samuels
Secretary, General Counsel & Senior Vice President at BeiGene Ltd.
Education
BA
Class of 1992
Memberships
Editor-in-Chief
Prior
Career History
Acting General Counsel & Secretary
Current

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

Secretary, General Counsel & Senior Vice President
Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Member (Attorney)
Prior

Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services and resources. The company offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. It was founded in 1933 and is headquartered in Boston, MA.

Transactions
Details Hidden

BeiGene Ltd. issued HKD Ordinary Shares

Details Hidden

BeiGene Ltd. issued USD American Depositary Shares

Details Hidden

BeiGene Ltd. issued USD American Depositary Shares

Awards & Honors
Admitted to the Pennsylvania Bar
Admitted to the Massachusetts Bar
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Scott Samuels. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Scott Samuels's profile does not indicate a business or promotional relationship of any kind between RelSci and Scott Samuels.